RNSG 1301 EXAM ONE QUESTIONS
AND CORRECT ANSWERS.
Generic drugs - Answer drugs sold by their generic name; not brand (or trade) name products
Brand name - Answer name given to a drug by the pharmaceutical company that developed
it; also called a trade name
Genetic drugs vs Brand name - Answer Once the patent on a brand name runs out
manufactures develop genetic drugs which are intended work on in the same way (quality,
dosage, strength, and route of administration).
The bioavailability of the generic drugs may differ from the brand name. This is why providers
might specify "dispense as written" so brand name product may use especially in drugs that
have narrow safety margins.
Control substance - (C-I) Schedule I - Answer High abuse potential and no accepted medical
use (heroin, marijuana, LSD)
Control substance - (C-II) Schedule II - Answer High abuse potential with severe dependence
liability (narcotics, amphetamines, and barbiturates)
Example: Cocaine, methamphetamines, methadone, Dilaudid, Demerol, Oxycodone, Fentanyl,
Morphine, Adderall, Ritalin, Dexedrine.
Written prescription only, no refills
Control substance - (C-III) Schedule III - Answer Less abuse potential than schedule II drugs
and moderate dependence liability (nonbarbiturate sedatives, nonamphetamine stimulants,
limited amounts of certain narcotics)
< 15 mg hydrocodone per dosage unit (Vicodin) ; < 90 mg of codeine p3er dosage unit (Tylenol
w/ codeine); ketamine; anabolic steroids; testosterone
Written/Oral Rx that expired w/n 6mos. No more than 5 refills.
Control substance - (C-IV) Schedule IV - Answer Less abuse potential than schedule III and
limited dependence liability (some sedatives, antianxiety agents, and nonnarcotic analgesics)
, Examples: Xanax, Soma, Valium, Ativan, Talwin, Ambien
Written/Oral Rx that expires w/n 6 mons. No more than 5 refills.
Control substance - (C-V) Schedule V - Answer Limited abuse potential
Cough suppressants < 200 mg codeine/100 mL (Robitussin AC), Lomotil, Motofen, Lyrica,
Parepectolin
Written Rx or OTC; must be 18 yo, ID must be showed, and dispensing must be recorded
The Controlled Substances Act of 1970 - Answer Control over the coding of drugs and the
enforcement of these codes to the FDA and the Drug Enforcement Agency (DEA), a part of the
U.S. Department of Justice.
Pregnancy category A - Answer Adequate studies in pregnant women have not demonstrated
a risk to the fetus in the first trimester of pregnancy, and there is no evidence of risk in later
trimesters.
Pregnancy category B - Answer Animal studies have not demonstrated a risk to the fetus but
there are no adequate studies in pregnant women.
Pregnancy category C - Answer Animal studies have shown an adverse effect on the fetus but
there are no adequate studies in humans; the benefits from the use of the drug in pregnant
women may be acceptable despite its potential risks, or there are no animal reproduction
studies and no adequate studies in humans.
Pregnancy category D - Answer There is evidence of human fetal risk, but the potential
benefits from the use of the drug in pregnant women may be acceptable despite its potential
risks.
Pregnancy category X - Answer Studies in animals or humans demonstrate fetal
abnormalities or adverse reaction; reports indicate evidence of fetal risk. The risk of use in a
pregnant woman clearly outweighs any possible benefit.
Pharmacotherapeutics - Answer clinical pharmacology—the branch of pharmacology that
deals with drugs; chemicals that are used in medicine for the treatment, prevention, and
diagnosis of disease in humans
AND CORRECT ANSWERS.
Generic drugs - Answer drugs sold by their generic name; not brand (or trade) name products
Brand name - Answer name given to a drug by the pharmaceutical company that developed
it; also called a trade name
Genetic drugs vs Brand name - Answer Once the patent on a brand name runs out
manufactures develop genetic drugs which are intended work on in the same way (quality,
dosage, strength, and route of administration).
The bioavailability of the generic drugs may differ from the brand name. This is why providers
might specify "dispense as written" so brand name product may use especially in drugs that
have narrow safety margins.
Control substance - (C-I) Schedule I - Answer High abuse potential and no accepted medical
use (heroin, marijuana, LSD)
Control substance - (C-II) Schedule II - Answer High abuse potential with severe dependence
liability (narcotics, amphetamines, and barbiturates)
Example: Cocaine, methamphetamines, methadone, Dilaudid, Demerol, Oxycodone, Fentanyl,
Morphine, Adderall, Ritalin, Dexedrine.
Written prescription only, no refills
Control substance - (C-III) Schedule III - Answer Less abuse potential than schedule II drugs
and moderate dependence liability (nonbarbiturate sedatives, nonamphetamine stimulants,
limited amounts of certain narcotics)
< 15 mg hydrocodone per dosage unit (Vicodin) ; < 90 mg of codeine p3er dosage unit (Tylenol
w/ codeine); ketamine; anabolic steroids; testosterone
Written/Oral Rx that expired w/n 6mos. No more than 5 refills.
Control substance - (C-IV) Schedule IV - Answer Less abuse potential than schedule III and
limited dependence liability (some sedatives, antianxiety agents, and nonnarcotic analgesics)
, Examples: Xanax, Soma, Valium, Ativan, Talwin, Ambien
Written/Oral Rx that expires w/n 6 mons. No more than 5 refills.
Control substance - (C-V) Schedule V - Answer Limited abuse potential
Cough suppressants < 200 mg codeine/100 mL (Robitussin AC), Lomotil, Motofen, Lyrica,
Parepectolin
Written Rx or OTC; must be 18 yo, ID must be showed, and dispensing must be recorded
The Controlled Substances Act of 1970 - Answer Control over the coding of drugs and the
enforcement of these codes to the FDA and the Drug Enforcement Agency (DEA), a part of the
U.S. Department of Justice.
Pregnancy category A - Answer Adequate studies in pregnant women have not demonstrated
a risk to the fetus in the first trimester of pregnancy, and there is no evidence of risk in later
trimesters.
Pregnancy category B - Answer Animal studies have not demonstrated a risk to the fetus but
there are no adequate studies in pregnant women.
Pregnancy category C - Answer Animal studies have shown an adverse effect on the fetus but
there are no adequate studies in humans; the benefits from the use of the drug in pregnant
women may be acceptable despite its potential risks, or there are no animal reproduction
studies and no adequate studies in humans.
Pregnancy category D - Answer There is evidence of human fetal risk, but the potential
benefits from the use of the drug in pregnant women may be acceptable despite its potential
risks.
Pregnancy category X - Answer Studies in animals or humans demonstrate fetal
abnormalities or adverse reaction; reports indicate evidence of fetal risk. The risk of use in a
pregnant woman clearly outweighs any possible benefit.
Pharmacotherapeutics - Answer clinical pharmacology—the branch of pharmacology that
deals with drugs; chemicals that are used in medicine for the treatment, prevention, and
diagnosis of disease in humans
